The Precision Paradox: Why Modern Oncology Requires Treating Less – Selectively
World Cancer Day 2026 creates a rare pause in oncology – not for awareness, but for recalibration. The theme, United by Unique, lands at a moment when the science is…
Misinformation: The Unmeasured Biomarker Shaping Outcomes
- Post category:Patient Communication/Supportive Oncology
- Reading time:3 mins read
The most precise cancer therapy means nothing if the patient declines it.That’s not a failure of medicine - it’s a failure of transmission. Patients now arrive with TikToks, chatbot printouts,…
Five Proven Systems Reducing Financial Toxicity at Diagnosis.
- Post category:Supportive Oncology
- Reading time:4 mins read
Financial toxicity isn’t a side effect of cancer treatment. It’s a predictable outcome of a care model that was never built to handle the cost of staying alive. We engineered…
How AI is Quietly Shaping Oncology – One Workflow at a Time
- Post category:Pan Cancer/Survivorship
- Reading time:4 mins read
Every oncologist today faces the same silent pressures:Infusion chairs full. Charts unfinished. Trial slots empty. Scans waiting for review. AI isn’t the future — it’s the quiet force turning those…
Germline Testing: The Therapeutic Biomarker You Can’t Afford to Miss
- Post category:Breast Cancer/Digestive (CRC, Stomach) System/Genitourinary (Prostate, Bladder) System/Gynecologic Cancer/Melanoma/Respiratory (Lung, Bronchus) System
- Reading time:2 mins read
You may already be ordering germline testing at rates well above the national average — but across the U.S., most eligible patients still aren’t tested: Ovarian cancer: ~39% receive germline…
Oncofertility Isn’t a Guidance Problem. It’s an Implementation Problem.
- Post category:Pan Cancer/Supportive Oncology/Survivorship
- Reading time:3 mins read
A patient recently confided, "When my husband was diagnosed with cancer at 32, no one spoke to us about fertility." That gap cost them a decade - and it was preventable. Nationwide, only…
